XML 19 R6.htm IDEA: XBRL DOCUMENT v3.23.3
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY (DEFICIT) (UNAUDITED) - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Additional Paid-in Capital
Additional Paid-in Capital
Cumulative Effect, Period of Adoption, Adjustment
Retained Earnings (Deficit)
Retained Earnings (Deficit)
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Dec. 31, 2021     3,122,000          
Beginning balance at Dec. 31, 2021 $ 51,867 $ (1,827) $ 936 $ 453,247 $ (5,651) $ (375,584) $ 3,824 $ (26,732)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net loss (32,462)         (32,462)    
Net settlement of vested stock awards 2     2        
Issuance of common stock (in shares)     1,190,000          
Issuance of common stock 9,768   $ 357 9,411        
Foreign currency translation adjustment, net of tax 346             346
Non-cash compensation (624)     (624)        
Ending balance (in shares) at Mar. 31, 2022     4,312,000          
Ending balance at Mar. 31, 2022 27,070   $ 1,293 456,385   (404,222)   (26,386)
Beginning balance (in shares) at Dec. 31, 2021     3,122,000          
Beginning balance at Dec. 31, 2021 51,867 $ (1,827) $ 936 453,247 $ (5,651) (375,584) $ 3,824 (26,732)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net loss [1] (76,887)              
Foreign currency translation adjustment, net of tax (12,152)              
Ending balance (in shares) at Sep. 30, 2022     4,322,000          
Ending balance at Sep. 30, 2022 (28,730)   $ 1,296 457,505   (448,647)   (38,884)
Beginning balance (in shares) at Mar. 31, 2022     4,312,000          
Beginning balance at Mar. 31, 2022 27,070   $ 1,293 456,385   (404,222)   (26,386)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net loss (21,552)         (21,552)    
Issuance of common stock (in shares)     10,000          
Issuance of common stock (71)   $ 3 (74)        
Foreign currency translation adjustment, net of tax (5,463)             (5,463)
Non-cash compensation 565     565        
Ending balance (in shares) at Jun. 30, 2022     4,322,000          
Ending balance at Jun. 30, 2022 549   $ 1,296 456,876   (425,774)   (31,849)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net loss (22,873)         (22,873)    
Foreign currency translation adjustment, net of tax (7,035)             (7,035)
Non-cash compensation 629     629        
Ending balance (in shares) at Sep. 30, 2022     4,322,000          
Ending balance at Sep. 30, 2022 $ (28,730)   $ 1,296 457,505   (448,647)   (38,884)
Beginning balance (in shares) at Dec. 31, 2022 4,342,909   4,343,000          
Beginning balance at Dec. 31, 2022 $ 117,760   $ 1,303 457,133   (301,679)   (38,997)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net loss (24,711)         (24,711)    
Net settlement of vested stock awards (in shares)     14,000          
Net settlement of vested stock awards (48)   $ 4 (52)        
Foreign currency translation adjustment, net of tax 755             755
Non-cash compensation 382     382        
Ending balance (in shares) at Mar. 31, 2023     4,357,000          
Ending balance at Mar. 31, 2023 $ 94,138   $ 1,307 457,463   (326,390)   (38,242)
Beginning balance (in shares) at Dec. 31, 2022 4,342,909   4,343,000          
Beginning balance at Dec. 31, 2022 $ 117,760   $ 1,303 457,133   (301,679)   (38,997)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net loss [1] (52,598)              
Foreign currency translation adjustment, net of tax $ (1,346)              
Ending balance (in shares) at Sep. 30, 2023 4,368,422   4,368,000          
Ending balance at Sep. 30, 2023 $ 64,615   $ 1,311 457,924   (354,277)   (40,343)
Beginning balance (in shares) at Mar. 31, 2023     4,357,000          
Beginning balance at Mar. 31, 2023 94,138   $ 1,307 457,463   (326,390)   (38,242)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net loss (15,753)         (15,753)    
Net settlement of vested stock awards (in shares)     11,000          
Net settlement of vested stock awards (12)   $ 4 (16)        
Foreign currency translation adjustment, net of tax 1,254             1,254
Non-cash compensation 245     245        
Ending balance (in shares) at Jun. 30, 2023     4,368,000          
Ending balance at Jun. 30, 2023 79,872   $ 1,311 457,692   (342,143)   (36,988)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net loss (12,134)         (12,134)    
Foreign currency translation adjustment, net of tax (3,355)             (3,355)
Non-cash compensation $ 232     232        
Ending balance (in shares) at Sep. 30, 2023 4,368,422   4,368,000          
Ending balance at Sep. 30, 2023 $ 64,615   $ 1,311 $ 457,924   $ (354,277)   $ (40,343)
[1] Condensed consolidated statement of cash flows for the nine months ended September 30, 2022 includes discontinued operations.